Frailty and heart failure: State‐of‐the‐art review
Journal of Cachexia, Sarcopenia and Muscle · 2023-10 · 14 (5) · 1959-1972
DOI: 10.1002/jcsm.13306 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 16.08.2023. Verfasst von Khawaja M Talha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA. Hauptthemen laut MEDLINE: Heart Failure, Frailty. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz, Gerontologische Pflege
Abstract (Originalsprache)
At least half of all patients with heart failure (HF) are affected by frailty, a syndrome that limits an individual ability to recover from acute stressors. While frailty affects up to 90% of patients with HF with preserved ejection fraction, it is also seen in ~30–60% of patients with HF with reduced ejection fraction, with ~26% higher prevalence in women compared with men. The relationship between frailty and HF is bidirectional, with both conditions exacerbating the other. Frailty is further complicated by a higher prevalence of sarcopenia (by ~20%) in HF patients compared with patients without HF, which negatively affects outcomes. Several frailty assessment methods have been employed historically including the Fried frailty phenotype and Rockwood Clinical Frailty Scale to classify HF patients based on the severity of frailty; however, a validated HF‐specific frailty assessment tool does not currently exist. Frailty in HF is associated with a poor prognosis with a 1.5‐fold to 2‐fold higher risk of all‐cause death and hospitalizations compared to non‐frail patients. Frailty is also highly prevalent in patients with worsening HF, affecting >50% of patients hospitalized for HF. Such patients with multiple readmissions for decompensated HF have markedly poor outcomes compared to younger, non‐frail cohorts, and it is hypothesized that it may be due to major physical and functional limitations that limit recovery from an acute episode of worsening HF, a care aspect that has not been addressed in HF guidelines. Frail patients are thought to confer less benefit from therapeutic interventions due to an increased risk of perceived harm, resulting in lower adherence to HF interventions, which may worsen outcomes. Multiple studies report that
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
- Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Division of Cardiology, Duke University Hospital, Duke University School of Medicine, Durham, NC, USA.
- Duke Clinical Research Institute, Durham, NC, USA.
- Baylor Scott and White Research Institute, Dallas, TX, USA.
- Department of Cardiology (CVK) of German Heart Center Charité, Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedi…
ORCID-Profile: Muhammad Shahzeb Khan
Zitieren
APA
Talha, K. M., Pandey, A., Fudim, M., Butler, J., Anker, S. D., & Khan, M. S. (2023). Frailty and heart failure: State‐of‐the‐art review. Journal of Cachexia, Sarcopenia and Muscle, 14(5), 1959-1972. https://doi.org/10.1002/jcsm.13306
Vancouver
Talha KM, Pandey A, Fudim M, Butler J, Anker SD, Khan MS. Frailty and heart failure: State‐of‐the‐art review. Journal of Cachexia, Sarcopenia and Muscle. 2023;14(5):1959-1972. doi:10.1002/jcsm.13306
BibTeX
@article{Talha2023,
author = {Talha, Khawaja M and Pandey, Ambarish and Fudim, Marat and Butler, Javed and Anker, Stefan D and Khan, Muhammad Shahzeb},
title = {Frailty and heart failure: State‐of‐the‐art review},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2023},
volume = {14},
number = {5},
pages = {1959--1972},
doi = {10.1002/jcsm.13306}
}
EUVIMED